Blood flow-metabolism mismatch: Good for the tumor, bad for the patient

Clinical Cancer Research

Volumn 15, Issue 17, 2009, Pages 5294-5296

  Mankoff, David A ^a,b   Dunnwald, Lisa K ^a   Partridge, Savannah C ^a   Specht, Jennifer M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Seattle Cancer Center Alliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; FLUORODEOXYGLUCOSE F 18; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; VASCULAR TARGETING AGENT; WATER O 15;

ANGIOGENESIS; BLOOD FLOW; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RELAPSE; CANCER SURVIVAL; CELL DEATH; CELL SURVIVAL; CONTRAST ENHANCEMENT; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; METABOLIC STRESS; MOLECULAR IMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TISSUE PERFUSION; TREATMENT RESPONSE;

ENERGY METABOLISM; GLUCOSE; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; REGIONAL BLOOD FLOW;

EID: 69949095183     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1448     Document Type: Note

References (12)

1. Komar G, Kauhanen S, Liukko K, et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res 2009;15:5511-5517
2. Tune JD, Gorman MW, Feigl EO. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 2004;97:404-415
3. Jain RK. Antiangiogenic therapy for cancer: current and emerging concepts. Oncology 2005;19:7-16.
4. Thompson CB, Bauer DE, Lum JJ, et al. How do cancer cells acquire the fuel needed to support cell growth? Cold Spring Harb Symp Quant Biol 2005;70:357-362
5. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732
6. Warburg O. The metabolism of tumors. New York: Richard R. Smith; 1931.
7. Miles KA, Williams RE. Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 2008;8:81-86
8. Dunnwald LK, Gralow JR, Ellis GK, et al. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 2008;26:4449-4457
9. Semple SI, Gilbert FJ, Redpath TW, et al. The relationship between vascular and metabolic characteristics of primary breast tumours. Eur Radiol 2004;14:2038-2045
10. Schelbert HR. PET contributions to understanding normal and abnormal cardiac perfusion and metabolism. Ann Biomed Eng 2000;28:922-929
11. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J Nucl Med 2004;45:1829-1837.
12. Morrish F, Neretti N, Sedivy JM, Hockenbery DM. The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle 2008;7:1054-1066 (Pubitemid 351679838)